




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Heart Transplant</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=2fbb8575-3ee6-4d6f-8bad-591a0603ecb0</link>
        <description>Clinical Topic Feed: Heart Transplant</description>
        <language>en</language>

        

                <item>
                    <title>Hot Topics in Congenital and Pediatric Cardiology in the Year 2025</title>
<link>/Latest-in-Cardiology/Articles/2026/02/19/11/58/Hot-Topics-in-Congenital-and-Pediatric-Cardiology-in-the-Year-2025</link>                    <description>The pace of innovation in congenital and pediatric cardiology continued to accelerate in 2025, shaped by practice&#226;€‘defining guidelines, multicenter investigations, and growing bench&#226;€‘to&#226;€‘bedside translation.</description>
                    <pubdate>1771850460000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>REUP For DCD Feasible Regardless of Donor Age, Ischemic Time</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/01/22/18/26/REUP-For-DCD</link>                    <description>Rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) was found to be feasible regardless of donor age and ischemic time, according to a study published Jan. 26 in JAMA.</description>
                    <pubdate>1769520060000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>For the FITs | Fighting Against the Tide: Graduate Training in AHFTC</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/For-the-FITs</link>                    <description>Over the past four decades, the field of advanced heart failure/transplant cardiology (AHFTC) has undergone remarkable transformation in both clinical practice and fellowship training.</description>
                    <pubdate>1761999120000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC in a Flash | LAAO Insights; Acoramidis Reduces CV Mortality, Rehospitalization; More</title>
<link>/Latest-in-Cardiology/Articles/2025/11/01/01/JACC-in-a-Flash</link>                    <description>Featured topics and Editors&#39; Picks from all of ACC&#39;s JACC Journals.</description>
                    <pubdate>1761998940000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New Insights Into Outcomes With Acoramidis in ATTR-CM, Danicamtiv in DCM</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/09/30/13/39/New-Insights-Into-Outcomes-With-Acoramidis</link>                    <description>Research highlighting acoramidis in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and danicamtiv for dilated cardiomyopathy (DCM) were presented during the Heart Failure Society of America (HFSA) 2025 meeting, held Sept. 26-29 in Minneapolis, MN, and simultaneously published in JACC.</description>
                    <pubdate>1759241400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Partial Heart Transplant Viable Option For Children With Congenital Valve Disease</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/09/19/16/45/Partial-Heart-Transplant</link>                    <description>Partial heart transplant provides a safe and effective valve replacement alterative with the capacity for valve growth in children with congenital heart disease, decreasing the need for reoperation, according to a small retrospective study published Aug. 27 in JAMA.</description>
                    <pubdate>1758300420000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Rethinking IABP in HF-CS: Insights From Altshock-2</title>
<link>/Latest-in-Cardiology/Articles/2025/08/05/14/29/Rethinking-IABP-in-HF-CS</link>                    <description>A 65-year-old woman with nonischemic cardiomyopathy on guideline-directed medical therapy presents with acute decompensated heart failure. While initially stable on standard therapy, she develops heart failure&#226;€“associated cardiogenic shock (HF-CS) despite initiation of diuretics...</description>
                    <pubdate>1754413740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Novel DCD Techniques: Rapid Recovery With Extended Ultraoxygenated Preservation; Pediatric On-Table Reanimation</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/07/23/18/12/Novel-DCD-Techniques</link>                    <description>Donation after circulatory death (DCD) without thoracoabdominal normothermic regional perfusion or commercial ex situ perfusion systems is possible using a novel technique &#226;€“ rapid recovery with extended ultraoxygenated preservation (REUP)...</description>
                    <pubdate>1753297980000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>AV after TTVR; Deep Learning in Automating Cardiac IMG; Survival Benefits Post-2018 Heart Transplantation Policy Change </title>
<link>/Latest-in-Cardiology/Articles/2025/07/16/19/08/eagles-eye-view-16jul2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at predictors of high-grade atrioventricular block (AV) after transcatheter tricuspid valve replacement (TTVR).</description>
                    <pubdate>1752681600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Higher Survival Benefit After 2018 U.S. Heart Transplantation Allocation Policy Change</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/07/10/09/09/Higher-Survival-Benefit-After-2018</link>                    <description>The 2018 U.S. heart allocation policy change has resulted in an increased survival benefit of heart transplantation due to improved stratification and prioritization of transplant candidates, according to a study published July 7 in JACC: Heart Failure.</description>
                    <pubdate>1752154980000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>